Dynavax Technologies Profit Margin

The latest profit margin for DVAX is -13.13% as of September 2025. That compares with 7.89% in the prior-year period — down 266.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Dynavax Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, DVAX's profit margin moved from 7.89% to -13.13% — a 266.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dynavax Technologies's valuation or profitability profile.

Against Healthcare companies, DVAX currently prints -13.13% for profit margin, while the sector average sits near 13.89%. That is roughly 194.5% below the sector mean. Large gaps often invite a closer look at Dynavax Technologies's growth, margins, and balance sheet.

Profit Margin shows how effectively Dynavax Technologies converts resources into returns. At -13.13%, DVAX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 7.89% in the prior-year period — down 266.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DVAX's profit margin (-13.13%), review year-over-year change from 7.89%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.